<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NLRX1 Protein</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[NLRX1](/genes/nlrx1)</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>NLRX1</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9NWV8</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~103 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Mitochondrial outer membrane</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>NOD-like receptor family</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ischemia" style="color:#ef9a9a">Ischemia</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">28 edges</a></td>
</tr>
</table>
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">NLRX1 Protein</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[NLRX1](/genes/nlrx1)</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>NLRX1</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9NWV8</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~103 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Mitochondrial outer membrane</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>NOD-like receptor family</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/autoimmune" style="color:#ef9a9a">Autoimmune</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ischemia" style="color:#ef9a9a">Ischemia</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">28 edges</a></td>
</tr>
</table>
NLRX1 (NOD-like Receptor Family Member X1) is a mitochondrial antiviral signaling protein that serves as a critical regulator of innate immune responses and mitochondrial function[@moore2008]. As a member of the NLR (NOD-like receptor) family, NLRX1 is uniquely localized to the mitochondria outer membrane, where it interfaces cellular metabolism with inflammatory signaling pathways that are highly relevant to neurodegenerative disease pathogenesis[@kigerl2022].
NLRX1 contains multiple functional domains that mediate its interactions with various signaling proteins:
NLRX1 was originally identified as a positive regulator of RIG-I-like receptor (RLR) signaling in antiviral immune responses. Upon viral infection, NLRX1 interacts with MAVS (Mitochondrial Antiviral Signaling Protein) on the mitochondrial surface, enhancing the downstream activation of [NF-κB](/entities/nf-kb) and type I interferon signaling pathways[@moore2008].
NLRX1 plays a crucial role in regulating mitochondrial [reactive oxygen species](/entities/reactive-oxygen-species) (ROS) production. Through its interactions with components of the electron transport chain, NLRX1 helps maintain mitochondrial homeostasis and prevents excessive ROS generation that could damage cellular components[@yang2020].
NLRX1 negatively regulates several inflammasome complexes, including NLRP3 and AIM2 inflammasomes. This regulation occurs through direct protein-protein interactions and competitive binding with upstream activators, limiting excessive inflammatory responses that could contribute to chronic neuroinflammation[@kigerl2022].
In Alzheimer's disease (AD), NLRX1 has emerged as a protective factor against [amyloid-beta](/proteins/amyloid-beta) (Aβ)-induced neurotoxicity. Studies demonstrate that NLRX1 expression is upregulated in AD brain tissue, particularly in regions vulnerable to amyloid pathology[@liu2021]. The protein appears to:
NLRX1 participates in pathways highly relevant to Parkinson's disease (PD) pathogenesis:
In ALS, NLRX1 is implicated in:
NLRX1 represents a potential therapeutic target for neurodegenerative diseases due to its central position at the intersection of mitochondrial function and innate immunity. Strategies under investigation include:
Key open questions in NLRX1 research include: